Lv31
230 积分 2024-02-06 加入
Neoadjuvant immunotherapy in mismatch-repair-proficient colon cancers
1小时前
待确认
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
1个月前
已完结
Evolving roles of MET as a therapeutic target in NSCLC and beyond
1个月前
已完结
Siglec ligand immunohistochemistry reveals association with immune exclusion and survival
3个月前
已关闭
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade
3个月前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
3个月前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
5个月前
已完结
The Biomarkers for Bevacizumab in first-line chemotherapy
5个月前
已完结
VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials
6个月前
已完结
Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
7个月前
已关闭
皖公网安备34019202002308
